These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 36197455)
1. Vindoline ameliorates intestinal barrier damage in Crohn's disease mice through MAPK signaling pathway. Zhang X; Zuo L; Geng Z; Song X; Li J; Ge S; Jiang Y; Yang Z; Liu G; Zhao Y; Zhao H; Yu L; Hu J FASEB J; 2022 Nov; 36(11):e22589. PubMed ID: 36197455 [TBL] [Abstract][Full Text] [Related]
2. Sotetsuflavone ameliorates Crohn's disease-like colitis by inhibiting M1 macrophage-induced intestinal barrier damage via JNK and MAPK signalling. Ge S; Yang Y; Zuo L; Song X; Wen H; Geng Z; He Y; Xu Z; Wu H; Shen M; Ge Y; Sun X Eur J Pharmacol; 2023 Feb; 940():175464. PubMed ID: 36566007 [TBL] [Abstract][Full Text] [Related]
3. Sclareol protected against intestinal barrier dysfunction ameliorating Crohn's disease-like colitis via Nrf2/NF-B/MLCK signalling. Wang L; Song X; Zhou Y; Xia Y; Yang Z; Chen X; Shi R; Geng Z; Zhang X; Wang Y; Li J; Hu J; Zuo L Int Immunopharmacol; 2024 May; 133():112140. PubMed ID: 38669952 [TBL] [Abstract][Full Text] [Related]
4. Peiminine ameliorates Crohn's disease-like colitis by enhancing the function of the intestinal epithelial barrier through Nrf2/HO1 signal. Qiu Q; Geng Z; Wang L; Zuo L; Deng M; Zhang H; Yang Y; Wang Y; Zhao Z; Wen H; Wang Q; Wang Y; He X; Li J; Wang Y; Zhang X; Liu M; Song X Int Immunopharmacol; 2024 Jul; 136():112380. PubMed ID: 38850790 [TBL] [Abstract][Full Text] [Related]
5. The JNK/P38 signalling pathway activated by testin protects the intestinal epithelial barrier against Crohn's disease-like colitis. Song X; Zhang X; Zhang M; Liu S; Zhang N; Liu X; Li B; Li J; Geng Z; Zuo L; Wang Y; Wang L; Hu J Chem Biol Interact; 2024 Nov; 403():111222. PubMed ID: 39237074 [TBL] [Abstract][Full Text] [Related]
6. Arjunolic acid protects the intestinal epithelial barrier, ameliorating Crohn's disease-like colitis by restoring gut microbiota composition and inactivating TLR4 signalling. Zhang Z; Zuo L; Song X; Wang L; Zhang Y; Cheng Y; Huang J; Zhao T; Yang Z; Zhang H; Li J; Zhang X; Geng Z; Wang Y; Ge S; Hu J Phytomedicine; 2024 Jan; 123():155223. PubMed ID: 38134862 [TBL] [Abstract][Full Text] [Related]
7. Magnolin inhibits intestinal epithelial cell apoptosis alleviating Crohn's disease-like colitis by suppressing the PI3K/AKT signalling pathway. Zhang M; Song X; Liu S; Zhang N; Yang M; Gao P; Geng Z; Zuo L; Zhang X; Wang L; Wang Y; Li J; Hu J Int Immunopharmacol; 2024 Jun; 134():112181. PubMed ID: 38733829 [TBL] [Abstract][Full Text] [Related]
8. Bergapten enhances mitophagy to regulate intestinal barrier and Th17/Treg balance in mice with Crohn's disease-like colitis via PPARγ/NF-κB signaling pathway. Xu L; Zhao B; Cheng H; Li G; Sun Y Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7589-7597. PubMed ID: 38664245 [TBL] [Abstract][Full Text] [Related]
9. Artemisinin ameliorates intestinal inflammation by skewing macrophages to the M2 phenotype and inhibiting epithelial-mesenchymal transition. Huai M; Zeng J; Ge W Int Immunopharmacol; 2021 Feb; 91():107284. PubMed ID: 33359851 [TBL] [Abstract][Full Text] [Related]
10. Sophoricoside improved Crohn's disease-like colitis by inhibiting intestinal epithelial cell apoptosis through PI3K/AKT signaling. Li Q; Li J; Yin L; Huang J; Liu X; Shi J; Geng Z; Song X; Wang L; Wang Y; Zhang X; Zuo L; Hu J Int Immunopharmacol; 2024 Apr; 131():111886. PubMed ID: 38493691 [TBL] [Abstract][Full Text] [Related]
11. [Pachymic acid protects against Crohn's disease-like intestinal barrier injury and colitis in miceby suppressingintestinal epithelial cell apoptosis Shao R; Yang Z; Zhang W; Zhang N; Zhao Y; Zhang X; Zuo L; Ge S Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jun; 43(6):935-942. PubMed ID: 37439165 [TBL] [Abstract][Full Text] [Related]
12. [Prunetin inhibits TLR4/MyD88 pathway to attenuate intestinal epithelial inflammatory response and ameliorate mouse Crohn's disease-like colitis]. Li J; Sun Y; Xiong X; Wang M; Zuo L; Wang Y; Geng Z Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2024 Mar; 40(3):199-206. PubMed ID: 38512029 [TBL] [Abstract][Full Text] [Related]
13. Decreased TMIGD1 aggravates colitis and intestinal barrier dysfunction via the BANF1-NF-κB pathway in Crohn's disease. Zhou L; Zhu L; Wu X; Hu S; Zhang S; Ning M; Yu J; Chen M BMC Med; 2023 Aug; 21(1):287. PubMed ID: 37542259 [TBL] [Abstract][Full Text] [Related]
14. Epac-2 ameliorates spontaneous colitis in Il-10 Song X; Wen H; Zuo L; Geng Z; Nian J; Wang L; Jiang Y; Tao J; Zhu Z; Wu X; Wang Z; Zhang X; Yu L; Zhao H; Xiang P; Li J; Shen L; Hu J J Cell Mol Med; 2022 Jan; 26(1):216-227. PubMed ID: 34862717 [TBL] [Abstract][Full Text] [Related]
15. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease. Tang R; Yang G; Zhang S; Wu C; Chen M Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103 [TBL] [Abstract][Full Text] [Related]
16. hUC-MSCs therapy for Crohn's disease: efficacy in TNBS-induced colitis in rats and pilot clinical study. Sun Q; Li S; Lin R; Zhao G; Lu J; Liu B; Hu M; Wang W; Yang X; Wei Y; Jia W; Hu Y; Zhang W; Zhu J; Cui D; Zhong L EBioMedicine; 2024 May; 103():105128. PubMed ID: 38653187 [TBL] [Abstract][Full Text] [Related]
17. Zhikang Capsule ameliorates dextran sodium sulfate-induced colitis by inhibition of inflammation, apoptosis, oxidative stress and MyD88-dependent TLR4 signaling pathway. Fei L; Xu K J Ethnopharmacol; 2016 Nov; 192():236-247. PubMed ID: 27452656 [TBL] [Abstract][Full Text] [Related]
18. Aloin A prevents ulcerative colitis in mice by enhancing the intestinal barrier function via suppressing the Notch signaling pathway. Jiang H; Shi GF; Fang YX; Liu YQ; Wang Q; Zheng X; Zhang DJ; Zhang J; Yin ZQ Phytomedicine; 2022 Nov; 106():154403. PubMed ID: 36075180 [TBL] [Abstract][Full Text] [Related]